Research Brief
Examining Possible Causes of Gulf War Illness: RAND Policy Investigations and Reviews of the Scientific Literature
Nov 25, 2005
Volume 1: Infectious Diseases
Format | List Price | Price | |
---|---|---|---|
Add to Cart | Paperback140 pages | $15.00 | $12.00 20% Web Discount |
Numerous Gulf War veterans have reported a range of illnesses and symptoms after serving in the Persian Gulf. Some of the reported symptoms are similar to those caused by diseases known to be prevalent in that region. This report discusses these infectious diseases and considers them as potential causes of the symptoms reported by the veterans. The authors present a short summary of etiology, diagnosis, and treatment for several infectious diseases and infectious organisms, including bacterial, viral, and parasitic infections. Two biological agents, anthrax and botulinum toxin, are also discussed.
Preface
Figures
Figure
Tables
Summary
Acknowledgements
Acknowledgments
Chapter One
Introduction
Chapter Two
Infectious Diseases As a Possible Cause of Gulf War Illnesses
Chapter Three
Bacterial Diseases (Mycoplasma)
Chapter Four
Bacterial Diseases (Other Than Mycoplasma)
Chapter Five
Viral Diseases
Chapter Six
Parasitic Diseases
Chapter Seven
Biological Warfare Agents
Chapter Eight
Unidentified Infections
Chapter Nine
Conclusions and Recommendations
Appendix
Additional Consideration on Mycoplasma
Bibliography
This research was sponsored by RAND’s National Security Research Division and RAND Health.
This report is part of the RAND Corporation Monograph report series. The monograph/report was a product of the RAND Corporation from 1993 to 2003. RAND monograph/reports presented major research findings that addressed the challenges facing the public and private sectors. They included executive summaries, technical documentation, and synthesis pieces.
Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit www.rand.org/about/research-integrity.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.